Symbio
USEntry
2023
Hold
3yr
Status
Active
Who owns Symbio?
Symbio is currently owned by ARCHIMED through MED Platform II (2022 vintage), since 2023. Across its history, Symbio has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Ownership history
2 ownership periods
Active
ARCHIMEDActive
2023 · present(3yr) · MED Platform II · 2022 · Buyout
More from MED Platform II
Other portfolio companies in the same fund.
ItalyMore PE-backed in Pharma
Comparable pharma deals from other GPs.
FranceTrack Symbio
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Symbio?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Symbio.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue